RJA
CSLT

Raymond James & Associates’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Raymond James & Associates’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,400
Closed -$21K – 4348
2021
Q3 		$21K Buy
13,400
+2,400
+22% +$4.7K ﹤0.01% 4005
2021
Q2 		$29K Sell
11,000
-600
-5% -$1.12K ﹤0.01% 3956
2021
Q1 		$18K Hold
11,600
– – ﹤0.01% 3923
2020
Q4 		$15K Sell
11,600
-1,800
-13% -$2.02K ﹤0.01% 3714
2020
Q3 		$15K Sell
13,400
-3,000
-18% -$3.3K ﹤0.01% 3522
2020
Q2 		$14K Buy
16,400
+300
+2% +$223 ﹤0.01% 3466
2020
Q1 		$12K Sell
16,100
-1,600
-9% -$1.78K ﹤0.01% 3430
2019
Q4 		$24K Sell
17,700
-14,500
-45% -$20.2K ﹤0.01% 3605
2019
Q3 		$45K Sell
32,200
-8,200
-20% -$16.3K ﹤0.01% 3481
2019
Q2 		$130K Sell
40,400
-10,328
-20% -$35.6K ﹤0.01% 3364
2019
Q1 		$190K Buy
50,728
+7,243
+17% +$23K ﹤0.01% 3259
2018
Q4 		$94K Sell
43,485
-10,015
-19% -$24.8K ﹤0.01% 3314
2018
Q3 		$144K Buy
53,500
+1,500
+3% +$5.3K ﹤0.01% 3377
2018
Q2 		$221K Sell
52,000
-1,200
-2% -$4.51K ﹤0.01% 3204
2018
Q1 		$194K Sell
53,200
-700
-1% -$2.6K ﹤0.01% 3143
2017
Q4 		$202K Sell
53,900
-8,500
-14% -$34K ﹤0.01% 3055
2017
Q3 		$268K Sell
62,400
-18,300
-23% -$75.4K ﹤0.01% 2864
2017
Q2 		$335K Sell
80,700
-3,300
-4% -$12.9K ﹤0.01% 2655
2017
Q1 		$307K Sell
84,000
-2,800
-3% -$9.83K ﹤0.01% 2692
2016
Q4 		$430K Sell
86,800
-6,350
-7% -$28.8K ﹤0.01% 2423
2016
Q3 		$388K Buy
93,150
+13,500
+17% +$55.1K ﹤0.01% 2450
2016
Q2 		$315K Buy
79,650
+4,800
+6% +$18.8K ﹤0.01% 2387
2016
Q1 		$249K Sell
74,850
-11,350
-13% -$37.3K ﹤0.01% 2457
2015
Q4 		$368K Sell
86,200
-10,500
-11% -$45.1K ﹤0.01% 2116
2015
Q3 		$406K Sell
96,700
-74,650
-44% -$471K ﹤0.01% 2011
2015
Q2 		$1.4M Buy
171,350
+70,300
+70% +$586K 0.01% 1545
2015
Q1 		$784K Sell
101,050
-16,650
-14% -$142K ﹤0.01% 1803
2014
Q4 		$1.38M Sell
117,700
-4,273
-4% -$51K 0.01% 1378
2014
Q3 		$1.58M Buy
121,973
+39,623
+48% +$523K 0.01% 1219
2014
Q2 		$1.25M Buy
+82,350
New +$1.34M 0.01% 1361

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
SCM
SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's CSLT Position: Q4 2021 in Review

Raymond James & Associates sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q4 2021, closing a stake of 13,400 shares — an estimated $21K sold.

Raymond James & Associates first reported a position in CSLT in Q2 2014 and held it in 30 quarters. The position peaked at $1.58M in Q3 2014. 106 funds tracked by Wall St. Rank hold CSLT as of Q4 2021.

  • Raymond James & Associates reported no remaining CASTLIGHT HEALTH, INC. position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 13,400 CASTLIGHT HEALTH, INC. shares in Q4 2021, an estimated $21K.
  • Raymond James & Associates first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and held it in 30 quarters.
  • Raymond James & Associates's CASTLIGHT HEALTH, INC. position peaked at $1.58M in Q3 2014.
  • 106 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.